{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/69545da8cb029db7575279fc/69545e0330165a956ded4dda?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"“Apple’s got a Stage 5 Clinger” — Jamf’s IPO. DraftKings Opening Day drama. Ro hits $1.5B","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/69545da8cb029db7575279fc/e3c5fab68347359b8c74030838b8871e.jpeg?height=200","description":"DraftKings shares dropped 6% because baseball just had its first mid-season COVID crisis. Jamf stock has doubled since its IPO because it’s got a single mission: Help your company thrive on Apple devices. And our “Unicorn of the Day” is Ro, whose valuation tripled to $1.5B by evolving beyond cheap direct-to-consumer Viagra to all of healthcare.\nLearn more about your ad choices. Visit podcastchoices.com/adchoices","author_name":"Nick & Jack Studios"}